Jeffrey Eastham‐Anderson

Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

Yan Zheng, Dimitry M. Danilenko, Patricia Valdez et al. · Nature · 2006 · 1.8K citations

Inflammation, Cytokine, Il-23-induced Dermal Inflammation +9

Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

Martin Schwickart, Xiaodong Huang, Jennie R. Lill et al. · Nature · 2009 · 614 citations

Deubiquitinase Usp9x, Medicine, Cancer Cell Biology +5

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

Séverine Vermeire, Sharon O’Byrne, Mary Keir et al. · The Lancet · 2014 · 449 citations · Full text

Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)

H Zhang, J Chen, Sajid Khan Tahir et al. · Cell Death and Disease · 2015 · 427 citations · Full text

DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury

Trent A. Watkins, Bei Wang, Sarah Huntwork‐Rodriguez et al. · Proceedings of the National Academy of Sciences · 2013 · 336 citations · Full text

Cell Death, Optogenetics, Social Sciences +21